IRF5 and breast cancer: Based on data in Fig. 3 showing that t-dEVs from IRF5-low OS and BC cell lines are capable of mediating a PMN that enables metastasis, we sought to characterize alterations in the lung stroma and immune microenvironment that may facilitate metastatic growth.